Jun 29, 2026-- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the U.S. Food and Drug Administration ( FDA) has granted premarket approval ( PMA) of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results